内視鏡超音波の世界市場規模：製品タイプ別、用途別、エンドユーザー別、地域別、範囲および予測

内視鏡超音波の市場規模と予測

内視鏡超音波市場規模は、2024年に11億8,000万米ドルと評価され、2026年から2032年にかけてCAGR 6.5%で成長し、2032年には18億7,000万米ドルに達すると予測されています。

内視鏡超音波検査（EUS）は、内視鏡と超音波を使用して消化管とその周辺の組織や臓器の詳細な画像を取得し、診断と治療の目的で高解像度の画像を提供する医療処置です。

超音波内視鏡検査は、食道がん、膵がん、大腸がんなどの消化管（GI）がんの診断や病期分類に広く用いられています。

また、膵炎、胆石、嚢胞などの良性疾患の評価にも用いられます。EUSは生検用の組織サンプルを採取するための細針吸引（FNA）を可能にし、正確な診断と治療計画の立案に役立ちます。

さらに、膵仮性嚢胞のドレナージ、疼痛管理のための腹腔神経叢神経弛緩術、ステントの誘導注射や留置などの治療応用もあります。

内視鏡超音波の将来は、診断および治療能力を強化する技術的進歩が予想されるため、有望です。

世界の内視鏡超音波市場力学

主な市場促進要因

消化器疾患の有病率の増加：消化器がんやその他の消化器疾患の罹患率の増加は、早期発見と治療成果を向上させるために、内視鏡超音波（EUS）のような高度な診断ツールに対する需要を促進しています。米国国立がん研究所によると、大腸がんは米国で3番目に多いがんであり、2022年には15万1,030人が新たに罹患すると推定されています。

技術の進歩：高解像度画像や低侵襲技術など、EUS機器の絶え間ない技術革新は診断精度を高め、治療応用の幅を広げ、市場成長を後押ししています。米国食品医薬品局（FDA）が2024年に承認した新たな内視鏡機器は前年比20％増の12件であり、この分野の技術革新のペースの速さを浮き彫りにしています。

低侵襲手技の採用拡大：患者の回復時間と関連リスクを軽減する低侵襲の診断・治療手技が好まれ、臨床現場でのEUSの採用が加速しています。メディケア＆メディケイド・サービスセンター（Centers for Medicare &Medicaid Services）は、2020年から2024年にかけての外来内視鏡処置件数が15％増加すると報告しているが、これはこの動向を反映したものです。患者の回復時間と関連リスクを軽減するEUS手技は、ますます普及しています。

老年人口の増加：世界人口の高齢化により、加齢に伴う消化管疾患の有病率が増加し、効果的な管理・治療のためにEUSのような高度な診断手技が必要となります。世界保健機関（WHO）は、2015年から2050年にかけて世界の60歳以上人口の割合が12％から22％へとほぼ倍増すると予測しています。この人口動態の変化がEUSの需要を押し上げると予想されます。

ヘルスケア支出の増加：特に発展途上地域におけるヘルスケア支出の増加は、EUSを含む先進医療技術の導入と導入を後押しし、質の高い診断・治療サービスへのアクセスを向上させる。世界銀行は、GDPに占める世界のヘルスケア支出の割合が2010年の9.7％から2022年には10.2％に増加すると報告しており、これはヘルスケア・サービスやテクノロジーへの投資が拡大していることを示しています。この動向は、質の高い診断・治療サービスへのアクセスを向上させています。

主な課題

熟練した専門家の不足：EUSの手技は複雑であるため、専門的なトレーニングや専門知識が必要とされるが、十分なトレーニングを受けた専門家の不足は、市場の成長とこの技術の普及を妨げる可能性があります。

厳しい規制要件：厳格な承認プロセスや規制基準への準拠は、新たなEUS機器や技術の導入を遅らせ、市場の拡大や技術革新に影響を与える可能性があります。

合併症や副作用のリスク：EUSは低侵襲ではあるが、感染、出血、穿孔などのリスクを伴うため、患者や医療提供者がこの診断法を選択することを躊躇する可能性があります。

代替画像診断法との競合：MRIやCTスキャンなど、消化器疾患の診断に有効な他の高度画像技術が利用できるようになると、EUSの需要が制限され、市場成長に影響を及ぼす可能性があります。

主要動向

人工知能（AI）の統合：AIと機械学習をEUSシステムに組み込んで画像解析と解釈を強化し、診断精度と効率を向上させ、より正確で個別化された治療計画を可能にする動きが加速しています。米国立衛生研究所（NIH）は2024年、AIによるEUS診断では、従来の方法と比較して早期膵臓がん発見が15％改善したと報告しました。最近の動向では、2024年7月10日、オリンパス株式会社が新しいAI搭載EUSプラットフォームの発売を発表し、処置時間の30％短縮と病変検出率の向上を約束しました。

装置の小型化：EUSプローブや機器の小型化が進み、手技の低侵襲化と患者の快適性が向上しています。欧州消化管内視鏡学会（ESGE）は2024年、EUSプローブの平均直径が過去5年間で25％縮小し、患者の不快感を大幅に軽減したと報告しました。この動向は、特に外来患者におけるEUSの適用範囲を拡大しています。

治療用途の拡大：診断だけでなく、標的薬剤の送達、嚢胞のドレナージ、腫瘍の切除など、治療的介入にEUSを利用するケースが増えており、臨床的有用性が拡大し、市場成長の原動力となっています。米国消化器内視鏡学会（ASGE）の報告によると、EUSガイド下介入は2019年から2024年の間に40%増加し、嚢胞ドレナージや腫瘍切除などの手技が最も高い成長を示しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 内視鏡超音波市場：製品タイプ別

• ラジアル超音波内視鏡（EUS）
• リニア内視鏡超音波（EUS）
• コンベックス内視鏡超音波（EUS）
• フェーズドアレイ超音波内視鏡（EUS）
• ドップラー超音波内視鏡（EUS）

第5章 内視鏡超音波市場：用途別

• 消化器
• 腫瘍学
• 呼吸器科
• 婦人科
• 泌尿器科

第6章 内視鏡超音波市場：エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 診断センター
• 診療所

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Olympus Corporation
• PENTAX Medical（HOYA Corporation）
• FUJIFILM Corporation
• Hitachi Medical Systems
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Endoscopy Ultrasound Market Size And Forecast

Endoscopy Ultrasound Market size was valued at USD 1.18 Billion in 2024 and is projected to reach USD 1.87 Billion by 2032, growing at a CAGR of 6.5% from 2026 to 2032.

Endoscopic ultrasound (EUS) is a medical procedure that uses an endoscope and ultrasound to obtain detailed images of the digestive tract and surrounding tissues and organs, providing high-resolution imaging for diagnostic and therapeutic purposes.

Endoscopic ultrasound is widely used in the diagnosis and staging of gastrointestinal (GI) cancers, such as esophageal, pancreatic, and colorectal cancers.

It is also employed to evaluate benign conditions like pancreatitis, gallstones, and cysts. EUS enables fine-needle aspiration (FNA) to obtain tissue samples for biopsy, aiding in accurate diagnosis and treatment planning.

Additionally, therapeutic applications include drainage of pancreatic pseudocysts, celiac plexus neurolysis for pain management, and guided injections or placements of stents.

The future of endoscopic ultrasound is promising due to anticipated technological advancements that will enhance its diagnostic and therapeutic capabilities.

Global Endoscopy Ultrasound Market Dynamics

The key market dynamics that are shaping the global endoscopy ultrasound market include:

Key Market Drivers

Increasing Prevalence of Gastrointestinal Diseases: The rising incidence of GI cancers and other digestive disorders drives demand for advanced diagnostic tools like endoscopic ultrasound (EUS) to improve early detection and treatment outcomes. According to the National Cancer Institute, colorectal cancer is the third most common cancer in the United States, with an estimated 151,030 new cases in 2022.

Technological Advancements: Continuous innovations in EUS equipment, such as high-resolution imaging and minimally invasive techniques, enhance diagnostic accuracy and broaden the range of therapeutic applications, boosting market growth. The U.S. Food and Drug Administration (FDA) approved 12 new endoscopic devices in 2024, a 20% increase from the previous year, highlighting the rapid pace of innovation in this field.

Growing Adoption of Minimally Invasive Procedures: The preference for minimally invasive diagnostic and therapeutic procedures, which reduce patient recovery time and associated risks, fuels the adoption of EUS in clinical settings. The Centers for Medicare & Medicaid Services reported a 15% increase in outpatient endoscopic procedures between 2020 and 2024, reflecting this trend. EUS procedures, which reduce patient recovery time and associated risks, are becoming increasingly popular.

Rising Geriatric Population: An aging global population increases the prevalence of age-related gastrointestinal conditions, necessitating advanced diagnostic procedures like EUS for effective management and treatment. The World Health Organization projects that the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. This demographic shift is expected to drive demand for EUS procedures.

Increasing Healthcare Expenditure: Higher healthcare spending, particularly in developing regions, supports the adoption and implementation of advanced medical technologies, including EUS, improving access to quality diagnostic and therapeutic services. The World Bank reported that global health expenditure as a percentage of GDP increased from 9.7% in 2010 to 10.2% in 2022, indicating growing investment in healthcare services and technologies. This trend is improving access to quality diagnostic and therapeutic services.

Key Challenges:

Limited Availability of Skilled Professionals: The complexity of EUS procedures necessitates specialized training and expertise, and the shortage of adequately trained professionals can hinder market growth and the widespread adoption of this technology.

Stringent Regulatory Requirements: The rigorous approval processes and compliance with strict regulatory standards can delay the introduction of new EUS devices and technologies, impacting market expansion and innovation.

Risk of Complications and Adverse Effects: Although minimally invasive, EUS procedures carry risks such as infection, bleeding, and perforation, which may deter patients and healthcare providers from opting for this diagnostic method.

Competition from Alternative Imaging Modalities: The availability of other advanced imaging technologies, such as MRI and CT scans, which are also effective in diagnosing GI conditions, can limit the demand for EUS, affecting market growth.

Key Trends

Integration of Artificial Intelligence (AI): AI and machine learning are being increasingly integrated into EUS systems to enhance image analysis and interpretation, improving diagnostic accuracy and efficiency, and enabling more precise and personalized treatment plans. The National Institutes of Health (NIH) reported in 2024 that AI-assisted EUS diagnoses showed a 15% improvement in early pancreatic cancer detection compared to traditional methods. In a recent development, on July 10, 2024, Olympus Corporation announced the launch of its new AI-powered EUS platform, promising a 30% reduction in procedure time and improved lesion detection rates.

Miniaturization of Equipment: Ongoing advancements in the miniaturization of EUS probes and devices are making procedures less invasive and more comfortable for patients, expanding the range of applications and facilitating adoption in outpatient settings. The European Society of Gastrointestinal Endoscopy (ESGE) reported in 2024 that the average diameter of EUS probes decreased by 25% over the past five years, significantly reducing patient discomfort. This trend has expanded the range of EUS applications, particularly in outpatient settings.

Expansion of Therapeutic Applications: Beyond diagnostics, EUS is increasingly being utilized for therapeutic interventions, such as targeted drug delivery, cyst drainage, and tumor ablation, broadening its clinical utility and driving market growth. The American Society for Gastrointestinal Endoscopy (ASGE) reported that EUS-guided interventions increased by 40% between 2019 and 2024, with procedures like cyst drainage and tumor ablation seeing the highest growth.

Global Endoscopy Ultrasound Market Regional Analysis

Here is a more detailed regional analysis of the global endoscopy ultrasound market:

North America

North America dominating the endoscopy ultrasound market due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a large pool of skilled professionals. According to the Centers for Disease Control and Prevention (CDC), gastrointestinal diseases affected approximately 70 million Americans in 2022, underscoring the growing need for advanced diagnostic and therapeutic tools like EUS.

The increasing prevalence of gastrointestinal diseases and robust healthcare expenditure further drive market growth in this region. The Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending reached USD 4.3 Trillion in 2024, with a notable portion allocated to advanced medical technologies like EUS. This substantial investment has facilitated the widespread adoption of cutting-edge EUS systems across healthcare institutions.

Government initiatives and funding for cancer research also contribute to the expanding use of EUS. For instance, in July 20, 2024, Pentax Medical, a key player in the EUS market, announced a partnership with a leading U.S. cancer research institute to develop a novel EUS-guided drug delivery system for pancreatic cancer treatment. This collaboration exemplifies the ongoing efforts to leverage EUS technology in advancing cancer care and solidifies North America's position at the forefront of EUS market growth.

Asia Pacific

The Asia-Pacific region is witnessing rapid growth in the endoscopic ultrasound (EUS) market, driven by substantial healthcare investments and an increasing prevalence of gastrointestinal disorders. According to the World Health Organization (WHO), healthcare spending in the Western Pacific region, which includes much of Asia, reached 6.6% of GDP in 2022, marking a significant increase from previous years.

This rising investment has directly contributed to improving healthcare infrastructure and the adoption of advanced medical technologies like EUS. The Asian Pacific Society for Digestive Endoscopy reported a 45% increase in EUS procedures across the region from 2020 to 2024, highlighting the growing acceptance and utilization of this technology.

China, Japan, and India are spearheading the expansion of the EUS market in the Asia-Pacific region. China's National Health Commission reported that the country's healthcare expenditure reached 7.12 trillion yuan (approximately USD 1.1 Trillion) in 2024, with a substantial portion allocated to upgrading medical equipment in hospitals.

The growing middle-class population and rising disposable incomes in the Asia-Pacific region are fueling the demand for advanced medical diagnostics and treatments. The Asian Development Bank estimated that 65% of the region's population will be middle class by 2025, up from 45% in 2015. This demographic shift has led to increased healthcare awareness and willingness to invest in advanced medical procedures.

Global Endoscopy Ultrasound Market: Segmentation Analysis

The Global Endoscopy Ultrasound Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

Based on Product Type, the Global Endoscopy Ultrasound Market is bifurcated into Radial-Endoscopic Ultrasound (EUS), Linear-Endoscopic Ultrasound (EUS), Curvilinear-Endoscopic Ultrasound (EUS), Phased Array-Endoscopic Ultrasound (EUS), and Doppler-Endoscopic Ultrasound (EUS). In the endoscopy ultrasound (EUS) market, linear-endoscopic ultrasound (EUS) is currently the dominant product type due to its widespread use in gastrointestinal diagnostics, providing detailed images for precise assessments of digestive tract conditions. Radial-endoscopic ultrasound (EUS) is the second rapidly growing segment, driven by its ability to offer comprehensive views of the surrounding structures, making it increasingly popular for evaluating pancreatic and bile duct conditions. Both product types are essential for enhancing diagnostic accuracy and are witnessing growth due to advancements in technology and increasing clinical applications.

Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

Based on Application, the Global Endoscopy Ultrasound Market is bifurcated into Gastroenterology, Oncology, Pulmonology, Gynecology, and Urology. In the endoscopy ultrasound (EUS) market, gastroenterology is the dominant application due to its extensive use in diagnosing and managing gastrointestinal conditions, such as cancers, pancreatitis, and bile duct abnormalities. Oncology is the second rapidly growing application, driven by the increasing need for precise staging and diagnosis of cancers, particularly in organs such as the pancreas and rectum, where EUS provides critical imaging for effective treatment planning and monitoring. Both applications are crucial in advancing diagnostic capabilities and improving patient outcomes in their respective fields.

Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

Based on End-User, the Global Endoscopy Ultrasound Market is bifurcated into Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Centers, and Clinics. In the endoscopy ultrasound (EUS) market, hospitals are the dominant end-user due to their comprehensive facilities and high volume of diagnostic and therapeutic procedures, which leverage EUS technology for advanced patient care. Ambulatory Surgical Centers (ASCs) are the second rapidly growing end-user, driven by the increasing preference for outpatient procedures and the need for minimally invasive diagnostics and treatments. ASCs offer a convenient and cost-effective setting for EUS procedures, contributing to their expanding role in the market.

Endoscopy Ultrasound Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Endoscopy Ultrasound Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the endoscopy ultrasound (EUS) market, North America is the dominant region, driven by its advanced healthcare infrastructure, high adoption of innovative medical technologies, and substantial healthcare expenditure. Asia-Pacific is the second rapidly growing region, fueled by increasing healthcare investments, rising prevalence of gastrointestinal disorders, and expanding healthcare infrastructure in countries like China, Japan, and India. The rapid growth in Asia-Pacific is supported by a rising middle-class population and greater accessibility to advanced medical diagnostics.

Key Players

The "Global Endoscopy Ultrasound Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Olympus Corporation, PENTAX Medical (HOYA Corporation), FUJIFILM Corporation, Hitachi Medical Systems, Boston Scientific Corporation, Cook Medical, Medtronic, CONMED Corporation, Medi-Globe GmbH, Limaca Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Endoscopy Ultrasound Market Key Developments

• In September 2024, Olympus Corporation introduced the UEV-400, a next-generation endoscopic ultrasound system featuring enhanced imaging resolution and real-time 3D visualization capabilities, aimed at improving diagnostic accuracy in gastrointestinal procedures.
• In June 2024, Fujifilm unveiled the EG-740UT, a new endoscopic ultrasound device with advanced needle guidance technology, designed to facilitate more precise biopsies and reduce procedure time in oncology applications.
• In March 2024, Pentax Medical announced a major upgrade to its EUS system with the release of the i-scan 3D, which integrates artificial intelligence to enhance image clarity and assist in the early detection of abnormalities.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

5. Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

6. Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Olympus Corporation
• PENTAX Medical (HOYA Corporation)
• FUJIFILM Corporation
• Hitachi Medical Systems
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References